Project 3: MANIPULATION OF GENE EXPRESSION WITH SMALL MOLECULES
Project 3: MANIPULATION OF GENE EXPRESSION WITH SMALL MOLECULES
批准号:
7556983
负责人:
Thomas J. Kodadek
金额:
$35.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2011-06-30
关键词:
AnimalsBindingBiological AssayBiomedical ResearchCellsCellular AssayCharacteristicsChromatinClassCollaborationsCultured CellsDiabetes MellitusGene ChipsGene ExpressionGene TargetingGenerationsGenesGenomeGoalsHandHoloenzymesHuman Cell LineIn VitroIsocitrate DehydrogenaseLaboratoriesLeadLibrariesLifeLinkLocalizedMapsMeasuresMetabolismNuclear ExtractNylonsPeptoidsPermeabilityPromoter RegionsPropertyProteinsRNA Polymerase IIRecruitment ActivityReportingSpecificitySynthetic GenesTherapeutic AgentsTransactivationWorkbasechromatin immunoprecipitationcombinatorialdesigndesirehuman CREB1 proteinimprovedisletnovelpromoterresearch studysmall moleculetooltranscription factor
中文摘要
该项目的目标是创造能够激活细胞的细胞渗透性合成分子。
特定基因的表达。"合成的转录因子模拟物"将能够定位于一个转录因子。
特异性启动子区域,并将转录机器募集到附近的基因,从而模拟一个启动子区域。
天然反式激活蛋白的基本功能。这些分子将是非常有用的工具,
生物医学研究,并可能被精心制作成一类新的治疗剂。
设想合成活化剂可以通过将DMA结合分子融合在一起来产生,
特别是具有适当的DMA识别特性的发夹聚酰胺,
能够结合RNA聚合酶II全酶,从而将其募集到靶启动子。有
来自我们实验室和其他人的大量证据表明,这是一种有效的方法,
已经报道了能够在核提取物中起作用的活化剂,
活细胞中的基因仍然难以捉摸。我们最近取得了令人兴奋的突破,
在活细胞中作为激活结构域等价物起作用的可渗透类肽。这是第一
观察这种活动。我们计划将这种拟肽和改进的衍生物与发夹聚酰胺连接,
合适的序列识别特性以产生细胞可渗透的合成活化剂。这些
化合物将用于操纵细胞系和人胰岛中的代谢。特别是要
试图激活Nkx6.1基因和胞质,NADPH依赖性异柠檬酸脱氢酶基因,
并确定这种刺激对细胞代谢的影响。这些研究将在
与Newgard实验室合作。根据Newgard实验室最近的结果,我们
他们还计划使用全基因组染色质免疫沉淀分析来帮助识别Nkx6.1的直接靶点
然后设计合成分子来开启这些基因。
在整个项目过程中,将不断努力开发更有效的
合成活化剂。为此,我们将利用我们开发的一种新的基于细胞的筛选方法,
其允许直接筛选合成的组合文库的活化结构域模拟物。
此外,我们还将建立细胞测定来优化聚酰胺与所需启动子的结合。
英文摘要
The goal of this project is to create cell permeable synthetic molecules capable of activating the
expression of specific genes. The "synthetic transcription factor mimics" would be capable of localizing to a
specific promoter region and recruiting the transcriptional machinery to a nearby gene, thus mimicking a
basic function of native transactivator proteins. These molecules would be tools of outstanding utility in
biomedical research and could potentially be elaborated into a new class of therapeutic agents.
It is envisioned that a synthetic activator could be created by fusing together a DMA-binding molecule,
specifically a hairpin polyamide with the appropriate DMA recognition characteristics, with a molecule
capable of binding the RNA polymerase II holoenzyme, thus recruiting it to the target promoter. There is
considerable evidence from our laboratory and others that this is a valid approach, but while synthetic
activators capable of functioning in nuclear extracts have been reported, the goal of molecules that function
in living cells remains elusive. We have recently made an exciting breakthrough with the discovery of a cell
permeable peptoid that functions as an activation domain equivalent in living cells. This is the first
observation of such activity. We plan to link this peptoid and improved derivatives to hairpin polyamides with
appropriate sequence recognition properties to create cell permeable synthetic activators. These
compounds will be employed to manipulate metabolism in cell lines and human islets. In particular, we will
attempt to activate the Nkx6.1 gene and the cytosolic, NADPH-dependent isocitrate dehydrogenase gene in
islets and determine the effect of this stimulation of the metabolism of the cell. These studies will be in
collaboration with the Newgard laboratory. Following the lead of recent results in the Newgard laboratory, we
also plan to use genome-wide chromatin immunoprecipitation assays to help to identify direct Nkx6.1 target
genes and will also then design synthetic molecules to turn on these genes as well.
Throughout the course of this project, consistent efforts will be made to develop ever more potent
synthetic activators. To do so, we will take advantage of a novel cell-based screen that we have developed
which allows synthetic combinatorial libraries to be screened for activation domain mimics directly.
Furthermore, we will also set up cellular assays to optimize polyamides for binding to the desired promoters.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Establishment of a Cell-Based Screening Platform for DNA Encoded Libraries
-
批准号:10646635
-
项目类别:
-
资助金额:$33.81万
-
财政年份:2023
-
负责人:Thomas J. Kodadek
-
依托单位:
Molecular Cloaking Devices for Manipulation of Cysteine Post-Translational Modifications
-
批准号:10507541
-
项目类别:
-
资助金额:$49.68万
-
财政年份:2022
-
负责人:Thomas J. Kodadek
-
依托单位:
Phenotypic screening using DNA-encoded libraries
-
批准号:10238888
-
项目类别:
-
资助金额:$59.51万
-
财政年份:2018
-
负责人:Thomas J. Kodadek
-
依托单位:
Phenotypic screening using DNA-encoded libraries
-
批准号:10622655
-
项目类别:
-
资助金额:$18.12万
-
财政年份:2018
-
负责人:Thomas J. Kodadek
-
依托单位:
Phenotypic screening using DNA-encoded libraries
-
批准号:10001013
-
项目类别:
-
资助金额:$77.15万
-
财政年份:2018
-
负责人:Thomas J. Kodadek
-
依托单位:
Discovery of Potent Proteasome Agonists to Improve Proteostasis
-
批准号:9388111
-
项目类别:
-
资助金额:$33.34万
-
财政年份:2017
-
负责人:Thomas J. Kodadek
-
依托单位:
Discovery of antibody biomarkers for Alzheimer’s Disease
-
批准号:9092101
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2016
-
负责人:Thomas J. Kodadek
-
依托单位:
Discovery of antibody biomarkers for Alzheimer’s Disease
-
批准号:9265411
-
项目类别:
-
资助金额:$19.2万
-
财政年份:2016
-
负责人:Thomas J. Kodadek
-
依托单位:
HTS for Direct Targeting of the Transcription Factor MITF
-
批准号:9109569
-
项目类别:
-
资助金额:$53.42万
-
财政年份:2014
-
负责人:Thomas J. Kodadek
-
依托单位:
Discovery and Treatment of the Early Autoimmune Reaction In Type 1 Diabetes
-
批准号:8240614
-
项目类别:
-
资助金额:$502.92万
-
财政年份:2011
-
负责人:Thomas J. Kodadek
-
依托单位:
MANIPULATION OF GENE EXPRESSION WITH SMALL MOLECULES
-
批准号:8147684
-
项目类别:
-
资助金额:$28.34万
-
财政年份:2010
-
负责人:Thomas J. Kodadek
-
依托单位:
Chemical Inhibitors of the Proteasomal ATPases
-
批准号:7905124
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2009
-
负责人:Thomas J. Kodadek
-
依托单位:
NOVEL MOLECULAR IMAGING AGENTS
-
批准号:7956957
-
项目类别:
-
资助金额:$1.78万
-
财政年份:2009
-
负责人:Thomas J. Kodadek
-
依托单位:
NEW CHEMISTRY FOR MULTIPROTEIN COMPLEXES
-
批准号:7724107
-
项目类别:
-
资助金额:$1.05万
-
财政年份:2008
-
负责人:Thomas J. Kodadek
-
依托单位:
NEW CHEMISTRY FOR MULTIPROTEIN COMPLEXES
-
批准号:7600841
-
项目类别:
-
资助金额:$1.51万
-
财政年份:2007
-
负责人:Thomas J. Kodadek
-
依托单位:
Novel Chemistry to Monitor and Manipulate the Immune System
-
批准号:7191786
-
项目类别:
-
资助金额:$78.5万
-
财政年份:2006
-
负责人:Thomas J. Kodadek
-
依托单位:
MANIPULATION OF GENE EXPRESSION WITH SMALL MOLECULES
-
批准号:7141450
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2006
-
负责人:Thomas J. Kodadek
-
依托单位:
Novel Chemistry to Monitor and Manipulate the Immune System
-
批准号:7292772
-
项目类别:
-
资助金额:$78.5万
-
财政年份:2006
-
负责人:Thomas J. Kodadek
-
依托单位:
Novel Chemistry to Monitor and Manipulate the Immune System
-
批准号:7919258
-
项目类别:
-
资助金额:$97.25万
-
财政年份:2006
-
负责人:Thomas J. Kodadek
-
依托单位:
NEW CHEMISTRY FOR MULTIPROTEIN COMPLEXES
-
批准号:7180723
-
项目类别:
-
资助金额:$1.05万
-
财政年份:2005
-
负责人:Thomas J. Kodadek
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: